Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
about
Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporterTargeting Acetylcholinesterase: Identification of Chemical Leads by High Throughput Screening, Structure Determination and Molecular ModelingAn Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.Neuroprotective properties of chitosan and its derivatives.Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer DiseaseTargeting acetylcholinesterase to treat neurodegeneration.Phenserine.New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine.Cholinesterase inhibitor (Altenuene) from an endophytic fungus Alternaria alternata: optimization, purification and characterization.Synthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitors.Synthesis and anticholinesterase activity and cytotoxicity of novel amide derivatives.Synthesis and biological evaluation of some pyrazoline derivatives bearing a dithiocarbamate moiety as new cholinesterase inhibitors.Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study.Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
P2860
Q24650088-10EC6948-0288-4468-9335-AC00D53C9EC6Q27675982-A0FFB43D-C890-403E-97CA-E07791899DF1Q33612147-55FAD104-4306-4A28-A338-AA6720AF530FQ34061851-0B71124D-D38E-4442-B524-C460161DFC77Q36273566-A8F83E30-5F0F-4282-845E-1FE2B34185FAQ36709537-90D93078-441B-4AA7-B0EE-837A03CF8665Q36861622-22738C91-51AC-42D5-B65E-03CE0C6BDA69Q38099889-CDFB078B-51F4-4ECC-BD62-159BCB5EA88BQ38162961-4D6D49EE-D420-435A-A985-320C9F122AB8Q41880802-3C5BE5DB-622E-4F6F-9AE7-B20DA405AFFEQ41991696-40E90ABF-B807-42A4-883C-5C4C5468BC46Q42800185-CD61DB16-45B0-454E-AB64-AAE1A9A8022FQ42804221-8E09C8BF-3BC6-4C87-A3E2-D9C7AAF0033BQ42825770-1799FA27-0FDA-4E4A-B2DA-9AE1C0CA8954Q43974783-33666B01-B889-4565-831E-6C8D49D81DC9Q48036245-340E4066-DDC5-40C9-99C7-DF3D269DE160Q57296260-CC9BB503-ADDE-478F-94A9-F5A1D63EBB1D
P2860
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@ast
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@en
type
label
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@ast
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@en
prefLabel
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@ast
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@en
P2860
P356
P1476
Novel cholinesterase inhibitor ...... atment of Alzheimer's disease.
@en
P2860
P356
10.1517/13543784.15.1.1
P407
P577
2006-01-01T00:00:00Z